Good Pharmacovigilance Practice Consultative Committee

The Pharmacovigilance Consultative Committee was established in November 2004 and meets twice yearly (one general and one technical meeting). The terms of reference of the meeting are to advise and provide information to representatives of trade associations and other government departments with respect to aspects of Good Pharmacovigilance Practice (GPvP) and GPvP inspections.
› Terms of Reference (10Kb) (updated November 2007)

Composition of the group includes representatives from the following trade associations:

• Association of British Pharmaceutical Industry (ABPI)
• British Association of Research Quality Assurance (BARQA)
• British Generic Manufacturers Association (BGMA)
• The Bioindustry Association (BIA)
• Ethical Medicines Industry Group (EMIG)
• Herbal Forum
• The Proprietary Association of Great Britain (PAGB)
• Pharmaceutical Information and Pharmacovigilance Association (PIPA)
• The Organisation for Professionals in Regulatory Affairs (TOPRA)

The technical meeting objectives are to provide a forum for discussion on all technical aspects of GPvP and to advise members on the interpretation of the principles of GPvP by the MHRA Inspectors.  Please also refer to our Frequently Asked Questions section for additional information on GPvP.

Minutes of the meetings are published on the MHRA website.

› Meeting Minutes 2 May 2008 (58Kb) | Questions for the Committee Meeting in May (42Kb)
› Meeting Minutes 2 November 2007
› Meeting Minutes 30 April 2007 (45Kb)

Contact for further information
For further information on this part of our site, please contact either:

1. Pharmacovigilance Inspectorate Unit, MHRA, Market Towers, 1 Nine Elms Lane, London, SW8 5NQ, telephone 020 7084 2606, fax 020 7084 3519  or e-mail info@mhra.gsi.gov.uk
2. Pharmacovigilance Inspectorate Unit, MHRA, 2 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW, telephone 01707 299130, fax 01707 376649 or e-mail info@mhra.gsi.gov.uk